2018-2023 Global Diabetes Devices Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Diabetes Devices market for 2018-2023.
Diabetes Devices adopts the method of data collection and analysis of diabetes care for patients with diabetes make reasonable prediction and control of diseases
As living standards improve, an increasing obesity, the equipment has improved people's living habits, disease control effect, is becoming more and more important
Over the next five years, LPI(LP Information) projects that Diabetes Devices will register a 5.9% CAGR in terms of revenue, reach US$ 30700 million by 2023, from US$ 21800 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Devices market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Blood glucose meters
Lancets
Blood glucose testing strips
Continuous glucose monitoring devices
Insulin syringes
Nsulin pumps
Insulin pens and injection
Segmentation by application:
Hospital
Personal Use
Home Use
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Becton
Dickinson and Company
Roche Diagnostics Ltd.
Johnson＆Johnson
Bayer AG
Abbott Laboratories
Acon Laboratories, Inc.
Ypsomed AG
Novo Nordisk A/S
Medtronic plc
ARKRAY Inc.
Terumo Corporation
Dexcom, Inc.
Sanofi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diabetes Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Diabetes Devices market by identifying its various subsegments.
Focuses on the key global Diabetes Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetes Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diabetes Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Diabetes Devices Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetes Devices Consumption 2013-2023
2.1.2 Diabetes Devices Consumption CAGR by Region
2.2 Diabetes Devices Segment by Type
2.2.1 Blood glucose meters
2.2.2 Lancets
2.2.3 Blood glucose testing strips
2.2.4 Continuous glucose monitoring devices
2.2.5 Insulin syringes
2.2.6 Nsulin pumps
2.2.7 Insulin pens and injection
2.3 Diabetes Devices Consumption by Type
2.3.1 Global Diabetes Devices Consumption Market Share by Type (2013-2018)
2.3.2 Global Diabetes Devices Revenue and Market Share by Type (2013-2018)
2.3.3 Global Diabetes Devices Sale Price by Type (2013-2018)
2.4 Diabetes Devices Segment by Application
2.4.1 Hospital
2.4.2 Personal Use
2.4.3 Home Use
2.4.4 Clinic
2.5 Diabetes Devices Consumption by Application
2.5.1 Global Diabetes Devices Consumption Market Share by Application (2013-2018)
2.5.2 Global Diabetes Devices Value and Market Share by Application (2013-2018)
2.5.3 Global Diabetes Devices Sale Price by Application (2013-2018)
3 Global Diabetes Devices by Players
3.1 Global Diabetes Devices Sales Market Share by Players
3.1.1 Global Diabetes Devices Sales by Players (2016-2018)
3.1.2 Global Diabetes Devices Sales Market Share by Players (2016-2018)
3.2 Global Diabetes Devices Revenue Market Share by Players
3.2.1 Global Diabetes Devices Revenue by Players (2016-2018)
3.2.2 Global Diabetes Devices Revenue Market Share by Players (2016-2018)
3.3 Global Diabetes Devices Sale Price by Players
3.4 Global Diabetes Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Diabetes Devices Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Diabetes Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diabetes Devices by Regions
4.1 Diabetes Devices by Regions
4.1.1 Global Diabetes Devices Consumption by Regions
4.1.2 Global Diabetes Devices Value by Regions
4.2 Americas Diabetes Devices Consumption Growth
4.3 APAC Diabetes Devices Consumption Growth
4.4 Europe Diabetes Devices Consumption Growth
4.5 Middle East & Africa Diabetes Devices Consumption Growth
5 Americas
5.1 Americas Diabetes Devices Consumption by Countries
5.1.1 Americas Diabetes Devices Consumption by Countries (2013-2018)
5.1.2 Americas Diabetes Devices Value by Countries (2013-2018)
5.2 Americas Diabetes Devices Consumption by Type
5.3 Americas Diabetes Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diabetes Devices Consumption by Countries
6.1.1 APAC Diabetes Devices Consumption by Countries (2013-2018)
6.1.2 APAC Diabetes Devices Value by Countries (2013-2018)
6.2 APAC Diabetes Devices Consumption by Type
6.3 APAC Diabetes Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Diabetes Devices by Countries
7.1.1 Europe Diabetes Devices Consumption by Countries (2013-2018)
7.1.2 Europe Diabetes Devices Value by Countries (2013-2018)
7.2 Europe Diabetes Devices Consumption by Type
7.3 Europe Diabetes Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diabetes Devices by Countries
8.1.1 Middle East & Africa Diabetes Devices Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Diabetes Devices Value by Countries (2013-2018)
8.2 Middle East & Africa Diabetes Devices Consumption by Type
8.3 Middle East & Africa Diabetes Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Diabetes Devices Distributors
10.3 Diabetes Devices Customer
11 Global Diabetes Devices Market Forecast
11.1 Global Diabetes Devices Consumption Forecast (2018-2023)
11.2 Global Diabetes Devices Forecast by Regions
11.2.1 Global Diabetes Devices Forecast by Regions (2018-2023)
11.2.2 Global Diabetes Devices Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diabetes Devices Forecast by Type
11.8 Global Diabetes Devices Forecast by Application
12 Key Players Analysis
12.1 Becton
12.1.1 Company Details
12.1.2 Diabetes Devices Product Offered
12.1.3 Becton Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Becton News
12.2 Dickinson and Company
12.2.1 Company Details
12.2.2 Diabetes Devices Product Offered
12.2.3 Dickinson and Company Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Dickinson and Company News
12.3 Roche Diagnostics Ltd.
12.3.1 Company Details
12.3.2 Diabetes Devices Product Offered
12.3.3 Roche Diagnostics Ltd. Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Roche Diagnostics Ltd. News
12.4 Johnson＆Johnson
12.4.1 Company Details
12.4.2 Diabetes Devices Product Offered
12.4.3 Johnson＆Johnson Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Johnson＆Johnson News
12.5 Bayer AG
12.5.1 Company Details
12.5.2 Diabetes Devices Product Offered
12.5.3 Bayer AG Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Bayer AG News
12.6 Abbott Laboratories
12.6.1 Company Details
12.6.2 Diabetes Devices Product Offered
12.6.3 Abbott Laboratories Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Abbott Laboratories News
12.7 Acon Laboratories, Inc.
12.7.1 Company Details
12.7.2 Diabetes Devices Product Offered
12.7.3 Acon Laboratories, Inc. Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Acon Laboratories, Inc. News
12.8 Ypsomed AG
12.8.1 Company Details
12.8.2 Diabetes Devices Product Offered
12.8.3 Ypsomed AG Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Ypsomed AG News
12.9 Novo Nordisk A/S
12.9.1 Company Details
12.9.2 Diabetes Devices Product Offered
12.9.3 Novo Nordisk A/S Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Novo Nordisk A/S News
12.10 Medtronic plc
12.10.1 Company Details
12.10.2 Diabetes Devices Product Offered
12.10.3 Medtronic plc Diabetes Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Medtronic plc News
12.11 ARKRAY Inc.
12.12 Terumo Corporation
12.13 Dexcom, Inc.
12.14 Sanofi
13 Research Findings and Conclusion
